These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1438 related articles for article (PubMed ID: 31699526)

  • 1. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center.
    Barchetti G; Simone G; Ceravolo I; Salvo V; Campa R; Del Giudice F; De Berardinis E; Buccilli D; Catalano C; Gallucci M; Catto JWF; Panebianco V
    Eur Radiol; 2019 Oct; 29(10):5498-5506. PubMed ID: 30887202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?
    Del Giudice F; Leonardo C; Simone G; Pecoraro M; De Berardinis E; Cipollari S; Flammia S; Bicchetti M; Busetto GM; Chung BI; Gallucci M; Catalano C; Panebianco V
    BJU Int; 2020 Nov; 126(5):610-619. PubMed ID: 32783347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and reliability of VI-RADS in determining candidates for repeated transurethral resection in patients with high-risk non-muscle invasive bladder cancer.
    Erkoc M; Otunctemur A; Bozkurt M; Can O; Atalay HA; Besiroglu H; Danis E; Degirmentepe RB
    Int J Clin Pract; 2021 Sep; 75(9):e14584. PubMed ID: 34185372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of VI-RADS in predicting muscle-invasive bladder cancer after transurethral resection: a single center retrospective analysis.
    Chai JL; Roller LA; Liu X; Lan Z; Mossanen M; Silverman SG; Shinagare AB
    Abdom Radiol (NY); 2024 May; 49(5):1593-1602. PubMed ID: 38502214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VI-RADS-based Algorithm for Bladder Cancer Management Randomized Retrospective Study.
    Şam Özdemir M; Keskin ET; Savun M; Yüzkan S; Kaya N; Özdemir H
    Urology; 2024 Dec; 194():225-230. PubMed ID: 39426738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel pathway to detect muscle-invasive bladder cancer based on integrated clinical features and VI-RADS score on MRI: results of a prospective multicenter study.
    Bicchetti M; Simone G; Giannarini G; Girometti R; Briganti A; Brunocilla E; Cardone G; De Cobelli F; Gaudiano C; Del Giudice F; Flammia S; Leonardo C; Pecoraro M; Schiavina R; Catalano C; Panebianco V
    Radiol Med; 2022 Aug; 127(8):881-890. PubMed ID: 35763251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of staging MRI to re-resection for localised bladder cancer: Narrative review.
    Klempfner H; Anderson P
    BJUI Compass; 2024 Jul; 5(7):651-661. PubMed ID: 39022656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of vesical imaging-reporting and data system (VI-RADS) in non-muscle invasive bladder cancer (NMIBC) patients candidate for en-bloc transurethral resection: A prospective study.
    El-Karamany TM; Al-Adl AM; Hosny MM; A Eldeep H; El-Hamshary SA
    Urol Oncol; 2022 Oct; 40(10):454.e1-454.e7. PubMed ID: 35466036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of multiparametric magnetic resonance imaging in bladder cancer (Vesical Imaging-Reporting and Data System): A systematic review.
    Carando R; Afferi L; Marra G; Krajewski W; Pagliarulo V; Abufaraj M; Xylinas E; Cathelineau X; Sanchez-Salas R; Moschini M
    Arab J Urol; 2020 Mar; 18(2):67-71. PubMed ID: 33029409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VI-RADS followed by Photodynamic Transurethral Resection of Non-Muscle-Invasive Bladder Cancer vs White-Light Conventional and Second-resection: the 'CUT-less' Randomised Trial Protocol.
    Del Giudice F; Vestri A; Fegatelli DA; Hüsch T; Belsey J; Nair R; Skinner EC; Chung BI; Pecoraro M; Sciarra A; Franco G; Pradere B; Gazzaniga P; Magloicca FM; Panebianco V; De Berardinis E
    BJU Int; 2024 Oct; ():. PubMed ID: 39397266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is high accuracy of Vesical Imaging-Reporting and Data System (VI-RADS) sufficient for its implementation in the urological practice?
    Rysankova K; Hanzlikova P; Zidlik V; Vrtkova A; Slisarenko M; Skarda J; Grepl M; Krhut J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Mar; 167(1):85-90. PubMed ID: 36628563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vesical Imaging-Reporting and Data System for Multiparametric MRI to Predict the Presence of Muscle Invasion for Bladder Cancer.
    Hong SB; Lee NK; Kim S; Son IW; Ha HK; Ku JY; Kim KH; Park WY
    J Magn Reson Imaging; 2020 Oct; 52(4):1249-1256. PubMed ID: 32220105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Additional MRI-Based Morphologic Measurements on the Performance of VI-RADS for Muscle-Invasive Bladder Cancer.
    Gong Y; Cheng Y; Zhang J; Bao ML; Zhu FP; Sun XY; Zhang YD
    J Magn Reson Imaging; 2024 Sep; 60(3):1113-1123. PubMed ID: 38258496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VI-RADS: Multiinstitutional Multireader Diagnostic Accuracy and Interobserver Agreement Study.
    Ueno Y; Tamada T; Takeuchi M; Sofue K; Takahashi S; Kamishima Y; Urase Y; Kido A; Hinata N; Harada K; Fujisawa M; Miyaji Y; Murakami T
    AJR Am J Roentgenol; 2021 May; 216(5):1257-1266. PubMed ID: 32755215
    [No Abstract]   [Full Text] [Related]  

  • 16. Could Bladder Multiparametric MRI Be Introduced in Routine Clinical Practice? Role of the New VI-RADS Score: Results From a Prospective Study.
    Marchioni M; Primiceri G; Delli Pizzi A; Basilico R; Berardinelli F; Mincuzzi E; Castellucci R; Sessa B; Di Nicola M; Schips L
    Clin Genitourin Cancer; 2020 Oct; 18(5):409-415.e1. PubMed ID: 32273236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biparametric versus Multiparametric Magnetic Resonance Imaging for Assessing Muscle Invasion in Bladder Urothelial Carcinoma with Variant Histology Using the Vesical Imaging-Reporting and Data System.
    Arita Y; Kwee TC; Woo S; Shigeta K; Ishii R; Okawara N; Edo H; Waseda Y; Vargas HA
    Eur Urol Focus; 2024 Jan; 10(1):131-138. PubMed ID: 37633790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) in suspected muscle invasive bladder cancer: A systematic review and diagnostic meta-analysis.
    Jazayeri SB; Dehghanbanadaki H; Hosseini M; Taghipour P; Alam MU; Balaji KC; Bandyk M
    Urol Oncol; 2022 Feb; 40(2):45-55. PubMed ID: 34895996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biparametric magnetic resonance imaging assessment for detection of muscle-invasive bladder cancer: a systematic review and meta-analysis.
    Ye L; Chen Y; Xu H; Xie H; Yao J; Liu J; Song B
    Eur Radiol; 2022 Sep; 32(9):6480-6492. PubMed ID: 35362750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic validity of the vesical imaging-reporting and data system (VI-RADS): a real-world study.
    Kazan O; Gunduz N; Bakir B; Iplikci A; Culpan M; Ersoy B; Yildirim A
    Actas Urol Esp (Engl Ed); 2023 Dec; 47(10):638-644. PubMed ID: 37209783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.